FIELD: steroids, pharmacy. SUBSTANCE: invention relates to the improved pharmaceutical preparations containing dehydroepiandrosterone enriched with polymorphic forms I or II and used for therapeutic aims. The preparation can comprise dehydroepiandrosterone as a solid form being at least 85% of its dose is presented as a common polymorph taken among polymorph from I or II and at least one pharmaceutical carrier. Composition shows the enhanced and stable bioaccumulating property. EFFECT: improved and valuable properties of composition. 34 cl, 4 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS WITH DEHYDROEPIANDROSTERONE | 2000 |
|
RU2248207C2 |
| METHOD FOR TREATMENT OF HUMAN SYSTEMIC LUPUS ERYTHEMATOSUS | 2015 |
|
RU2580301C1 |
| MACROCYCLIC POLYMORPHS, COMPOSITIONS CONTAINING SUCH POLYMORPHS, AND METHODS FOR USING AND PREPARING THEM | 2008 |
|
RU2478643C2 |
| TABLET COMPRISING DEHYDROEPIANDROSTERONE (DHEA) | 2012 |
|
RU2627111C2 |
| METHODS OF PRODUCTION ISOQUINOLINONES AND SOLID FORMS ISOQUINOLINONES | 2012 |
|
RU2626883C2 |
| METHODS OF TREATING AND/OR SUPPRESSING WEIGHT GROWTH | 2000 |
|
RU2519642C2 |
| METHOD FOR MASS INCREASE TREATMENT AND/OR INHIBITION | 2013 |
|
RU2636498C2 |
| METHOD OF MASS INCREASE TREATMENT AND/OR INHIITION | 2000 |
|
RU2327461C2 |
| NEUROPROTECTIVE 7-BETA-HYDROXYSTEROIDS | 2001 |
|
RU2258511C2 |
| NEUROGENESIS MEDIATED WITH 4-ACYLAMINOPYRIDINE DERIVATIVES | 2007 |
|
RU2451512C2 |
